CMA says tribunal “wrong” to overturn pharma fine
The UK’s Competition Appeal Tribunal erred on the test required for the Competition and Markets Authority to fine drugmakers for excessive pricing, the authority’s counsel has argued.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.